Journal of Lipids最新文献

{"title":"Utilization of Solid Waste as a Substrate for Production of Oil from Oleaginous Microorganisms.","authors":"Fortunate Laker,&nbsp;Arnold Agaba,&nbsp;Andrew Akatukunda,&nbsp;Robert Gazet,&nbsp;Joshua Barasa,&nbsp;Sarah Nanyonga,&nbsp;Deborah Wendiro,&nbsp;Alex Paul Wacoo","doi":"10.1155/2018/1578720","DOIUrl":"https://doi.org/10.1155/2018/1578720","url":null,"abstract":"<p><p>The overwhelming demand of oil and fats to meet the ever increasing needs for biofuel, cosmetics production, and other industrial purposes has enhanced a number of innovations in this industry. One such innovation is the use of microorganisms as alternative sources of oil and fats. Organic solid waste that is causing a big challenge of disposal worldwide is biodegradable and can be utilized as substrate for alternative oil production. The study evaluated the potential of isolated yeast-like colonies to grow and accumulate oil by using organic solid waste as substrate. Of the 25 yeast-like colonies isolated from the soil samples collected from three different suburbs in Kampala district, Uganda, 20 were screened positive for accumulation of lipid but only 2 were oleaginous. The NHC isolate with the best oil accumulation potential of 48.8% was used in the central composite design (CCD) experiments. The CCD experimental results revealed a maximum oil yield of 61.5% from 1.25 g/L cell biomass at 10 g/L of solid waste and temperature of 25°C. The study revealed that organic solid waste could be used as a substrate for microbial oil production.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2018 ","pages":"1578720"},"PeriodicalIF":5.3,"publicationDate":"2018-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/1578720","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36189344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of Locally Manufactured Niger Seed Oil on Lipid Profile Compared to Imported Palm and Sunflower Oils on Rat Models.","authors":"Zewdie Mekonnen,&nbsp;Abrha Gebreselema,&nbsp;Yohannes Abere","doi":"10.1155/2018/7846350","DOIUrl":"https://doi.org/10.1155/2018/7846350","url":null,"abstract":"<p><strong>Background: </strong>Different types of dietary lipids have been shown to affect lipid metabolism and lipid profile differently.</p><p><strong>Objective: </strong>This study aims to assess the effect of local niger seed oil on serum lipid profile compared to palm oil and sunflower oil in rats.</p><p><strong>Methods: </strong>The effect of the 15% plant oils on serum lipid profile, body weight gain percentage, and feed efficiency ratio was assessed after 8 weeks of experimental period.</p><p><strong>Results and conclusion: </strong>The 15% niger seed oil showed decrease and increase in the level of lipid profile as compared to rats fed with 15% palm oil and sunflower oil (except Triacylglycerol), respectively. The 15% niger seed oil showed significant decrease and increase in body weight gain percentage as compared to the 15% palm oil and 15% sunflower oil, respectively. The feed efficiency ratio was significantly higher and lower in the 15% niger seed oil compared to rats fed with 15% sunflower oil and control group and the palm oil fed rats, respectively. The current study concluded that consumption of locally manufactured niger seed oil decreased the blood lipid profiles, body weight gain percentage, and feed efficiency ratio as compared to palm oil. Utilization of oils containing more unsaturated fatty acids like niger seed oil is recommended to reduce the risk of developing cardiovascular disease.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2018 ","pages":"7846350"},"PeriodicalIF":5.3,"publicationDate":"2018-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/7846350","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36181908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and Efficacy of Extremely Low LDL-Cholesterol Levels and Its Prospects in Hyperlipidemia Management.","authors":"Dhrubajyoti Bandyopadhyay, Arshna Qureshi, Sudeshna Ghosh, Kumar Ashish, Lyndsey R Heise, Adrija Hajra, Raktim K Ghosh","doi":"10.1155/2018/8598054","DOIUrl":"10.1155/2018/8598054","url":null,"abstract":"<p><p>The risk of cardiovascular disease has been reported to have a linear relationship with LDL levels. Additionally, the currently recommended LDL target goal of 70 mg/dl does not diminish the CV risk entirely leaving behind some residual risk. Previous attempts to maximally lower the LDL levels with statin monotherapy have met dejection due to the increased side effects associated with the treatment. Nevertheless, with the new advancements in clinical medicine, it has now become possible to bring down the LDL levels to as low as 15 mg/dl using PCSK9 monoclonal antibodies alone or in combination with statins. The development of inclisiran, siRNA silencer targeting PCSK9 gene, is a one step forward in these endeavors. Moreover, various studies aiming to lower the CV risk and mortality by lowering LDL levels have demonstrated encouraging results. The current challenge is to explore this arena to redefine the target LDL levels, if required, to avoid any suboptimal treatment. After thorough literature search in the PubMed, Embase, Scopus, and Google Scholar, we present this article to provide a brief overview of the safety and efficacy of lowering LDL below the current goal.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2018 ","pages":"8598054"},"PeriodicalIF":5.3,"publicationDate":"2018-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/8598054","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36178366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of Supplementation with <i>n</i>-3 Fatty Acids Extracted from Microalgae on Inflammation Biomarkers from Two Different Strains of Mice.","authors":"L E Gutiérrez-Pliego,&nbsp;B E Martínez-Carrillo,&nbsp;A A Reséndiz-Albor,&nbsp;I M Arciniega-Martínez,&nbsp;J A Escoto-Herrera,&nbsp;C A Rosales-Gómez,&nbsp;R Valdés-Ramos","doi":"10.1155/2018/4765358","DOIUrl":"https://doi.org/10.1155/2018/4765358","url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus is considered a chronic noncommunicable disease in which inflammation plays a main role in the progression of the disease and it is known that <i>n</i>-3 fatty acids have anti-inflammatory properties. One of the most recent approaches is the study of the fatty acids of microalgae as a substitute for fish oil and a source rich in fatty acids EPA and DHA.</p><p><strong>Objective: </strong>To analyze the effect of supplementation with <i>n</i>-3 fatty acids extracted from microalgae on the inflammatory markers from two different strains of mice.</p><p><strong>Methods: </strong>Mice of two strains, db/db and CD1, were supplemented with <i>n</i>-3 fatty acids extracted from microalgae in lyophilized form and added to food; the experiment was carried out from week 8 to 16 of life. Flow cytometry was performed to determine the percentage of TCD4+ cells producing Th1 and Th2 cytokines.</p><p><strong>Results: </strong>Supplementation with microalgae fatty acids decreased the percentage of TCD4+ cells producing IFN-<i>γ</i> and TNF-<i>α</i> and increased the ones producing IL-17A and IL-12 in both strains; on the other hand, supplementation decreased percentage of TCD4+ cells producing IL-4 and increased the ones producing TGF-<i>β</i>.</p><p><strong>Conclusions: </strong>Microalgae <i>n-</i>3 fatty acids could be a useful tool in the treatment of diabetes as well as in the prevention of the appearance of health complications caused by inflammatory states.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2018 ","pages":"4765358"},"PeriodicalIF":5.3,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/4765358","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36136620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Correlation of Dyslipidemia with the Extent of Coronary Artery Disease in the Multiethnic Study of Atherosclerosis.","authors":"Moshrik Abd Alamir,&nbsp;Michael Goyfman,&nbsp;Adib Chaus,&nbsp;Firas Dabbous,&nbsp;Leslie Tamura,&nbsp;Veit Sandfort,&nbsp;Alan Brown,&nbsp;Mathew Budoff","doi":"10.1155/2018/5607349","DOIUrl":"https://doi.org/10.1155/2018/5607349","url":null,"abstract":"<p><strong>Background: </strong>The extent of coronary artery calcium (CAC) improves cardiovascular disease (CVD) risk prediction. The association between common dyslipidemias (combined hyperlipidemia, simple hypercholesterolemia, metabolic Syndrome (MetS), isolated low high-density lipoprotein cholesterol, and isolated hypertriglyceridemia) compared with normolipidemia and the risk of multivessel CAC is underinvestigated.</p><p><strong>Objectives: </strong>To determine whether there is an association between common dyslipidemias compared with normolipidemia, and the extent of coronary artery involvement among MESA participants who were free of clinical cardiovascular disease at baseline.</p><p><strong>Methods: </strong>In a cross-sectional analysis, 4,917 MESA participants were classified into six groups defined by specific LDL-c, HDL-c, or triglyceride cutoff points. Multivessel CAC was defined as involvement of at least 2 coronary arteries. Multivariate Poisson regression analysis evaluated the association of each group with multivessel CAC after adjusting for CVD risk factors.</p><p><strong>Results: </strong>Unadjusted analysis showed that all groups except hypertriglyceridemia had statistically significant prevalence ratios of having multivessel CAC as compared to the normolipidemia group. The same groups maintained statistical significance prevalence ratios with multivariate analysis adjusting for other risk factors including Agatston CAC score [combined hyperlipidemia 1.41 (1.06-1.87), hypercholesterolemia 1.55 (1.26-1.92), MetS 1.28 (1.09-1.51), and low HDL-c 1.20 (1.02-1.40)].</p><p><strong>Conclusion: </strong>Combined hyperlipidemia, simple hypercholesterolemia, MetS, and low HDL-c were associated with multivessel coronary artery disease independent of CVD risk factors and CAC score. These findings may lay the groundwork for further analysis of the underlying mechanisms in the observed relationship, as well as for the development of clinical strategies for primary prevention.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2018 ","pages":"5607349"},"PeriodicalIF":5.3,"publicationDate":"2018-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/5607349","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36118039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cardiovascular Outcomes of PCSK9 Inhibitors: With Special Emphasis on Its Effect beyond LDL-Cholesterol Lowering.","authors":"Dhrubajyoti Bandyopadhyay,&nbsp;Kumar Ashish,&nbsp;Adrija Hajra,&nbsp;Arshna Qureshi,&nbsp;Raktim K Ghosh","doi":"10.1155/2018/3179201","DOIUrl":"https://doi.org/10.1155/2018/3179201","url":null,"abstract":"<p><p>PCSK9 inhibitors, monoclonal antibodies, are novel antihypercholesterolemic drugs. FDA first approved them in July 2015. PCSK9 protein (692-amino acids) was discovered in 2003. It plays a major role in LDL receptor degradation and is a prominent modulator in low-density lipoprotein cholesterol (LDL-C) metabolism. PCSK9 inhibitors are monoclonal antibodies that target PCSK9 protein in liver and inhibiting this protein leads to drastically lowering harmful LDL-C level in the bloodstream. Despite widespread use of the statin, not all the high-risk patients were able to achieve targeted level of LDL-C. Using PCSK9 inhibitors could lead to a substantial decrement in LDL-C plasma level ranging from 50% to 70%, either as a monotherapy or on top of statins. A large number of trials have shown robust reduction of LDL-C plasma level with the use of PCSK9 inhibitors as a monotherapy or in combination with statins in familial and nonfamilial forms of hypercholesterolemia. Moreover, PCSK9 inhibitors do not appear to increase the risk of hepatic and muscle-related side effects. PCSK9 inhibitors proved to be a highly potent and promising antihypercholesterolemic drug by decreasing LDL-R lysosomal degradation by PCSK9 protein. Statin drugs are known to have some pleiotropic effects. In this article, we are also focusing on the effects of PCSK9 inhibitor beyond LDL-C reduction like endothelial inflammation, atherosclerosis, its safety in patients with diabetes, obesity, and chronic kidney disease, and its influence on neurocognition and stroke.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2018 ","pages":"3179201"},"PeriodicalIF":5.3,"publicationDate":"2018-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/3179201","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36106366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identification and Quantification of Fatty Acids in <i>T. viridissima</i>, <i>C. biguttulus</i>, and <i>C. brunneus</i> by GC-MS.","authors":"Alexander M Wathne,&nbsp;Hanne Devle,&nbsp;Carl Fredrik Naess-Andresen,&nbsp;Dag Ekeberg","doi":"10.1155/2018/3679247","DOIUrl":"https://doi.org/10.1155/2018/3679247","url":null,"abstract":"<p><p>Fatty acid (FA) profiles of the species <i>Tettigonia viridissima</i>, <i>Chorthippus biguttulus</i>, and <i>Chorthippus brunneus</i> were determined and quantitated. Extracted lipids were derivatized into FA methyl esters (FAMEs) prior to analysis by GC-MS. A total of 37 different FAs were identified in <i>T. viridissima</i>, yielding a total FA content of 10.4 g/100 g of dry matter. The contents of saturated FAs, monounsaturated FAs, and polyunsaturated FAs were 31.1, 35.9, and 33.0%, respectively. Lipids from <i>T. viridissima</i> were also fractioned into neutral lipids, free fatty acids, and polar lipids by offline solid phase extraction. For <i>C. brunneus</i> and <i>C. biguttulus</i>, 33 FAs were identified, yielding a total FA content of 6.14 g/100 g of dry matter. SFAs, MUFAs, and PUFAs, respectively, constituted 32.7, 25.1, and 42.1% of the total FA content. The contents of MUFAs, PUFAs, <i>n</i>-3 FAs, and <i>n</i>-6 FAs of each species, and the <i>n</i>-6/<i>n</i>-3 ratio, were subsequently discussed.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2018 ","pages":"3679247"},"PeriodicalIF":5.3,"publicationDate":"2018-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/3679247","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36034297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Realm of Thermoalkaline Lipases in Bioprocess Commodities.","authors":"Ahmad Firdaus B Lajis","doi":"10.1155/2018/5659683","DOIUrl":"10.1155/2018/5659683","url":null,"abstract":"<p><p>For decades, microbial lipases are notably used as biocatalysts and efficiently catalyze various processes in many important industries. Biocatalysts are less corrosive to industrial equipment and due to their substrate specificity and regioselectivity they produced less harmful waste which promotes environmental sustainability. At present, thermostable and alkaline tolerant lipases have gained enormous interest as biocatalyst due to their stability and robustness under high temperature and alkaline environment operation. Several characteristics of the thermostable and alkaline tolerant lipases are discussed. Their molecular weight and resistance towards a range of temperature, pH, metal, and surfactants are compared. Their industrial applications in biodiesel, biodetergents, biodegreasing, and other types of bioconversions are also described. This review also discusses the advance of fermentation process for thermostable and alkaline tolerant lipases production focusing on the process development in microorganism selection and strain improvement, culture medium optimization via several optimization techniques (i.e., one-factor-at-a-time, surface response methodology, and artificial neural network), and other fermentation parameters (i.e., inoculums size, temperature, pH, agitation rate, dissolved oxygen tension (DOT), and aeration rate). Two common fermentation techniques for thermostable and alkaline tolerant lipases production which are solid-state and submerged fermentation methods are compared and discussed. Recent optimization approaches using evolutionary algorithms (i.e., Genetic Algorithm, Differential Evolution, and Particle Swarm Optimization) are also highlighted in this article.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2018 ","pages":"5659683"},"PeriodicalIF":5.9,"publicationDate":"2018-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36019969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of Oil Content and Fatty Acids Profile of Western Schley, Wichita, and Native Pecan Nuts Cultured in Chihuahua, Mexico.","authors":"L R Rivera-Rangel, K I Aguilera-Campos, A García-Triana, J G Ayala-Soto, D Chavez-Flores, L Hernández-Ochoa","doi":"10.1155/2018/4781345","DOIUrl":"10.1155/2018/4781345","url":null,"abstract":"<p><p>Two different extraction processes, Soxhlet and ultrasound, were used to obtain the oil extracts of Western Schley, Wichita, and Native pecan nuts cultured in Chihuahua, Mexico. The aspects evaluated in this study were the extraction yield of the processes and fatty acids' profile of the resulting extracts. Gas chromatography coupled with mass spectrometry (GC-MS) was used to identify and determine the composition percentage of fatty acids present in pecan nuts oils extracted. The results obtained show that higher oil extraction yields were obtained by Soxhlet method with hexane (69.90%) in Wichita varieties. Wichita, Western Schley, and Native pecan nuts from Chihuahua are rich in PUFA (polyunsaturated fatty acids) and MUFA (monounsaturated fatty acids) and have low levels of SFA (saturated fatty acids). The predominant fatty acid present in all pecan nuts oils was linoleic acid followed by oleic acid. Myristic acid, palmitic acid, and linolenic acid were also identified in representative quantities. The results from this study suggest that there are statistically significant differences in the chemical composition of the pecan nuts oils extracted from the varieties cultured in Chihuahua, Mexico, and those cultivated in other regions of the world.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2018 ","pages":"4781345"},"PeriodicalIF":5.3,"publicationDate":"2018-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35972378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ceramide and Ischemia/Reperfusion Injury.","authors":"Xingxuan He,&nbsp;Edward H Schuchman","doi":"10.1155/2018/3646725","DOIUrl":"https://doi.org/10.1155/2018/3646725","url":null,"abstract":"<p><p>Ceramide, a bioactive membrane sphingolipid, functions as an important second messenger in apoptosis and cell signaling. In response to stresses, it may be generated by de novo synthesis, sphingomyelin hydrolysis, and/or recycling of complex sphingolipids. It is cleared from cells through the activity of ceramidases, phosphorylation to ceramide-1-phosphate, or resynthesis into more complex sphingolipids. Ischemia/reperfusion (IR) injury occurs when oxygen/nutrition is rapidly reintroduced into ischemic tissue, resulting in cell death and tissue damage, and is a major concern in diverse clinical settings, including organ resection and transplantation. Numerous reports show that ceramide levels are markedly elevated during IR. Mitochondria are major sites of reactive oxygen species (ROS) production and play a key role in IR-induced and ceramide-mediated cell death and tissue damage. During the development of IR injury, the initial response of ROS and TNF-alpha production activates two major ceramide generating pathways (sphingomyelin hydrolysis and de novo ceramide synthesis). The increased ceramide has broad effects depending on the IR phases, including both pro- and antiapoptotic effects. Therefore, strategies that reduce the levels of ceramide, for example, by modulation of ceramidase and/or sphingomyelinases activities, may represent novel and promising therapeutic approaches to prevent or treat IR injury in diverse clinical settings.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2018 ","pages":"3646725"},"PeriodicalIF":5.3,"publicationDate":"2018-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/3646725","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35971315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}